IntrinsicIntrinsic
← Scroll for more →

Financial Statements — LGVT

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024
Cash & Equivalents0.000.000.000.00--0.00--0.000.00
Accounts Payable0.00--0.01----------0.01
Total Current Liabilities0.100.080.07----0.05--0.040.03
Retained Earnings(14.32)(14.29)(14.29)(14.21)(14.21)(14.21)(14.18)(13.96)(13.95)
Total Stockholder Equity(0.10)(0.08)(0.07)(0.05)--(0.05)--(0.04)(0.03)
← Scroll for more columns →

Income Statement

(in thousands USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Selling, General & Admin30.0224.067.7520.31--284.10----37.85220.467.4318.36
Total Operating Expenses30.0224.067.7520.31--284.10----37.85220.467.4318.36
Operating Income(30.01)(24.06)(7.75)(20.31)--(284.10)----(37.85)(220.46)(7.43)(18.36)
Pretax Income(30.01)(24.06)(7.75)(20.31)--(284.10)----(37.85)(220.46)(7.43)(18.36)
Net Income(30.01)(24.06)(7.75)(20.31)(52.72)0.000.000.00(37.85)(220.46)(7.43)(18.36)
Basic EPS--0.00----------------0.000.00
Diluted EPS--0.00----------------0.000.00
← Scroll for more columns →

Cash Flow Statement

(in thousands USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2024Q3 2024Q2 2024Q1 2024
Operating Cash Flow(22.04)(19.97)(17.81)(44.39)13.70(18.01)(7.43)(28.36)
Financing Cash Flow22.0519.9717.8144.39(13.70)18.017.4328.36
← Scroll for more columns →